BioSenic S.A. (EBR:BIOS)
0.0020
0.00 (0.00%)
May 26, 2026, 10:35 AM CET
BioSenic Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 24,096 | 9.05 | 11.06 | 0.27 | 0.31 | |
Revenue Growth (YoY) | 266233.24% | -18.21% | 4058.42% | -14.74% | -91.49% |
Gross Profit | 24,096 | 9.05 | 11.06 | 0.27 | 0.31 |
Selling, General & Admin | - | - | - | 1.55 | 0.57 |
Depreciation & Amortization Expenses | 348.42 | 3.1 | 4 | - | - |
Research & Development | - | - | - | 1.03 | 0.62 |
Other Operating Expenses | 3,225 | 9.65 | 1.65 | 0 | - |
Total Operating Expenses | 3,573 | 12.75 | 5.66 | 2.58 | 1.19 |
Operating Income | 22,250 | -3.16 | -8.2 | -2.32 | -0.88 |
Interest Income | 1.69 | 0 | - | 0.01 | 0 |
Interest Expense | -23.19 | -1.58 | - | -0.74 | -0.11 |
Other Non-Operating Income (Expense) | - | -41.88 | -1.51 | - | 0 |
Total Non-Operating Income (Expense) | -21.51 | -43.45 | -1.51 | -0.73 | -0.11 |
Pretax Income | 22,228 | -46.62 | -9.71 | -3.05 | -0.98 |
Provision for Income Taxes | 0.3 | - | 0.01 | 0 | 0 |
Net Income | 22,228 | -46.62 | -9.7 | -3.05 | -0.98 |
Minority Interest in Earnings | - | - | - | -1.01 | 0 |
Net Income to Common | 22,228 | -46.62 | -9.7 | -2.04 | -0.98 |
Shares Outstanding (Basic) | 653 | 324 | 137 | 120 | 21 |
Shares Outstanding (Diluted) | 653 | 324 | 137 | 120 | 21 |
Shares Change (YoY) | 101.54% | 136.56% | 13.98% | 463.72% | 81.78% |
EPS (Basic) | 0.03 | -0.14 | -0.21 | -0.02 | -0.05 |
EPS (Diluted) | 0.03 | -0.14 | -0.21 | -0.02 | -0.05 |
Free Cash Flow | -1.05 | -3.06 | -5.41 | -2.05 | -1.07 |
Free Cash Flow Per Share | -0.00 | -0.01 | -0.04 | -0.02 | -0.05 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | 92.34% | -34.97% | -74.11% | -871.43% | -281.09% |
Profit Margin | 92.25% | -515.24% | -87.69% | -1146.24% | -315.38% |
FCF Margin | -0.00% | -33.79% | -48.94% | -768.80% | -341.99% |
EBITDA | 22,250 | -2.97 | -7.95 | -2.26 | -0.86 |
EBITDA Margin | 92.34% | -32.85% | -71.91% | -848.87% | -276.92% |
EBIT | 22,250 | -3.16 | -8.2 | -2.32 | -0.88 |
EBIT Margin | 92.34% | -34.97% | -74.11% | -871.43% | -281.09% |
Effective Tax Rate | 0.00% | 0.00% | -0.07% | 0.00% | 0.00% |